Computed Tomography-Guided Brachytherapy for Liver Cancer

Seminars in Radiation Oncology

Volumn 21, Issue 4, 2011, Pages 287-293

  Ricke, Jens ^a   Wust, Peter ^b  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; BLEEDING; BRACHYTHERAPY; CANCER RADIOTHERAPY; CATHETERIZATION; COMPUTER ASSISTED TOMOGRAPHY; DUODENUM ULCER; HUMAN; LIVER ABSCESS; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER METASTASIS; NAUSEA; PLEURA EFFUSION; PLEURODESIS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; REVIEW; SHIVERING; STOMACH ULCER; TREATMENT PLANNING; TUMOR RECURRENCE;

BRACHYTHERAPY; HUMANS; LIVER NEOPLASMS; RADIATION DOSAGE; RADIOTHERAPY, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80053046374     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2011.05.005     Document Type: Review

References (30)

1. Welsh F.K., Tekkis P.P., O'Rourke T. Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: An aid to clinical decision-making. Surg Oncol 2008, 17:3-13.
2. Berber E., Pelley R., Siperstein A.E. Predictors of survival after radio frequency thermal ablation of colorectal cancer metastases to the liver: A prospective study. J Clin Oncol 2005, 23:1358-1364.
3. Gillams A.R., Lees W.R. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 2009, 19:1206-1213.
4. Llovet J.M., Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 2008, 48(suppl 1):S20-S37.
5. Stang A., Fischbach R., Teichmann W., et al. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer 2009, 45:1748-1756.
6. Curley S.A. Radiofrequency ablation versus resection for resectable colorectal liver metastases: Time for a randomized trial?. Ann Surg Oncol 2008, 15:11-13.
7. Ricke J., Wust P., Stohlmann A., et al. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: Phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 2004, 58:1496-1505.
8. Ricke J., Wust P., Wieners G., et al. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J Vasc Interv Radiol 2004, 15:1279-1286.
9. Pech M., Wieners G., Kryza R., et al. CT-guided brachytherapy (CTGB) versus interstitial laser ablation (ILT) of colorectal liver metastases: An intraindividual matched-pair analysis. Strahlenther Onkol 2008, 184:302-306.
10. Denecke T., Lopez-Hänninen E. Brachytherapy of liver metastases. Recent Results Cancer Res 2008, 177:95-104.
11. Kang H.C., Shin K.H., Park S.Y., et al. 3D CT-based high-dose-rate brachytherapy for cervical cancer: Clinical impact on late rectal bleeding and local control. Radiother Oncol 2010, 97:507-513.
12. Guedea F., Venselaar J., Hoskin P., et al. Patterns of care for brachytherapy in Europe: Updated results. Radiother Oncol 2010, 97:514-520.
13. Tselis N., Kolotas C., Birn G., et al. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results. Strahlenther Onkol 2007, 183:563-570.
14. Ricke J., Mohnike K., Pech M., et al. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2010, 78:479-485.
15. Mohnike K., Wieners G., Schwartz F., et al. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: Safety, efficacy, and effect on survival. Int J Radiat Oncol Biol Phys 2010, 78:172-179.
16. Donath D., Nori D., Turnbull A., et al. Brachytherapy in the treatment of solitary colorectal metastases to the liver. J Surg Oncol 1990, 44:55-61.
17. Thomas D.S., Nauta R.J., Rodgers J.E., et al. Intraoperative high-dose rate interstitial irradiation of hepatic metastases from colorectal carcinoma. Results of a phase I-II trial. Cancer 1993, 71:1977-1981.
18. Dritschilo A., Harter K.W., Thomas D., et al. Intraoperative radiation therapy of hepatic metastases: Technical aspects and report of a pilot study. Int J Radiat Oncol Biol Phys 1988, 14:1007-1011.
19. Seidensticker M., Wust P., Rühl R., et al. Safety margin in irradiation of colorectal liver metastases: Assessment of the control dose of micrometastases. Radiol Oncol 2010, 5:24.
20. Wieners G., Pech M., Rudzinska M., et al. CT-guided interstitial brachytherapy in the local treatment of extrahepatic, extrapulmonary secondary malignancies. Eur Radiol 2006, 16:2586-2593.
21. Wieners G., Mohnike K., Peters N., et al. Treatment of hepatic metastases of breast cancer with CT-guided interstitial brachytherapy-A phase II-study. Radiother Oncol 2011, Apr 15, [Epub ahead of print].
22. Ricke J., Seidensticker M., Lüdemann L., et al. In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation. Int J Radiat Oncol Biol Phys 2005, 62:776-784.
23. Wybranski C., Seidensticker M., Mohnike K., et al. In vivo assessment of dose volume and dose gradient effects on the tolerance dose of small liver volumes after single-fraction high-dose-rate 192Ir irradiation. Radiat Res 2009, 172:598-606.
24. Herfarth K.K., Hof H., Bahner M.L., et al. Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 2003, 57:444-451.
25. Streitparth F., Pech M., Böhmig M., et al. In vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2006, 65:1479-1486.
26. Rühl R., Lüdemann L., Czarnecka A., et al. Radiobiological restrictions and tolerance doses of repeated single-fraction HDR-irradiation of intersecting small liver volumes for recurrent hepatic metastases. Radiol Oncol 2010, 5:44.
27. Rühl R., Seidensticker M., Peters N., et al. Hepatocellular carcinoma and liver cirrhosis: Assessment of the liver function after yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy. Dig Dis 2009, 27:189-199.
28. Ricke J., Wust P., Wieners G., et al. CT-guided interstitial single-fraction brachytherapy of lung tumors: Phase I results of a novel technique. Chest 2005, 127:2237-2242.
29. Peters N., Wieners G., Pech M., et al. CT-guided interstitial brachytherapy of primary and secondary lung malignancies: Results of a prospective phase II trial. Strahlenther Onkol 2008, 184:296-301.
30. Ricke J., Thormann M., Ludewig M., et al. MR-guided liver tumor ablation employing open high-field 1.0T MRI for image-guided brachytherapy. Eur Radiol 2010, 20:1985-1993.